Glycemic Control With Once-Weekly Basal Insulin Fc Therapy vs Once-Daily Insulin Degludec Therapy in Insulin-Naive Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Once-Weekly Basal Insulin Fc Demonstrated Similar Glycemic Control to Once-Daily Insulin Degludec in Insulin-Naive Patients With Type 2 Diabetes: A Phase 2 Randomized Control Trial
Diabetes Care 2023 May 01;46(5)1060-1067, JM Bue-Valleskey, CM Kazda, C Ma, J Chien, Q Zhang, E Chigutsa, W Landschulz, A Haupt, JP FriasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.